Previous Article | Next Article 
Applied and Environmental Microbiology, May 2005, p. 2438-2441, Vol. 71, No. 5
0099-2240/05/$08.00+0 doi:10.1128/AEM.71.5.2438-2441.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
Antimicrobial Resistance Profiles of Campylobacter jejuni Isolates from Wild Birds in Sweden
Jonas Waldenström,1,2
Dik Mevius,3*
Kees Veldman,3
Tina Broman,4
Dennis Hasselquist,2 and
Björn Olsen2,5,6
Department of Animal Ecology, Ecology Building, Lund University, SE-223 62 Lund,1
Ottenby Bird Observatory, Pl. 1500, SE-380 65 Degerhamn,2
Department of NBC Analysis, Swedish Defence Research Agency, Umeå,4
Department of Infectious Diseases, Umeå University, SE-901 87 Umeå,5
Department of Biology and Environmental Science, University of Kalmar, SE-391 82, Kalmar, Sweden,6
Central Institute for Animal Disease Control (CIDC), Lelystad, The Netherlands3
Received 18 June 2004/
Accepted 22 November 2004

ABSTRACT
In order to determine the occurrence and frequency of resistant
strains of the bacterium
Campylobacter jejuni and to establish
baseline MICs in isolates from an environmental reservoir, the
resistance profiles of 10 antimicrobial substances were determined
for 137
C. jejuni isolates from wild birds in Sweden. Observed
MICs were generally low, with only low to moderate incidence
of resistance to the tested compounds. One isolate, however,
was resistant to nalidixic acid and ciprofloxacin, indicating
that quinolone-resistant genotypes of
C. jejuni have the potential
to spread to wild bird hosts.

INTRODUCTION
Currently, there is an intense debate on the use and misuse
of antimicrobial agents in the raising of livestock for food
and their sometimes imprudent prescription for therapeutic use
in humans (
2,
12). From the farm perspective, animal health
and farm economics is balanced against the associated risk of
bacterial pathogens acquiring antimicrobial resistance (
7,
19).
As laws and control measures differ between countries, there
are often large variations between nations in their total and
per capita use of antimicrobial agents in both human and veterinary
medicine, with a general trend towards more unrestricted use
in developing countries.
The enteropathogens Campylobacter jejuni and Salmonella spp. represent an important public health problem. Domestic animals constitute a significant reservoir for these zoonotic agents that are typically food borne (17, 21). Resistance acquired by these bacteria in response to antimicrobial selection pressures in livestock production could severely hamper the treatment of human infections, especially when the same class of antimicrobial agents is used in the two systems (2, 26). In a worst-case scenario, with multiresistant bacteria, there would be few, if any, antimicrobial compounds available for clinical use.
One important question specifically addressed in the present study is whether resistant bacteria are directly or indirectly "leaking" out from humanmade systems into the environment. The study focuses on C. jejuni, one of the leading causes of acute bacterial gastroenteritis in humans (11), and analyzes the antimicrobial resistance profiles of C. jejuni isolates obtained from a large collection of wild birds. Important risk factors for acquiring C. jejuni infection include consumption of undercooked poultry meat, cross-contamination from poultry meat to other food products, and drinking inadequately pasteurized milk or untreated drinking water (3, 11, 23). There are, however, good reasons to believe that less well-known sources may be important in the epidemiology of the bacterium, as many outbreaks and sporadic cases are left unresolved (16, 20). Apart from the well-known poultry reservoir, C. jejuni occurs naturally in both domesticated and wild mammals and birds (27), and it has been isolated from surface and groundwater (16). Taken together, these elements set the stage for potential transfer of resistant strains in and out of food production systems.
In the present study, we determined the susceptibility of 137 C. jejuni strains isolated from free-flying healthy birds. The tested strains were chosen to represent three different groups of bird hosts: thrushes, shorebirds, and raptors, all previously known to harbor significant levels of C. jejuni (5, 27).

MATERIALS AND METHODS
Origin of strains.
The
C. jejuni strains investigated in this study came from ongoing
studies of the occurrence and distribution of
Campylobacter spp. in different free-flying bird species in Sweden. In this
project, birds were trapped and sampled at Ottenby Bird Observatory
(56° 12'N, 16° 24'E) when they stopped over in the area
during their northbound spring or southbound autumn migration.
For details on trapping, sampling, and primary isolation procedures,
see previously published descriptions (
6,
27). One-hundred thirty-nine
strains, presumptively identified as
C. jejuni based on morphology
and limited phenotypic testing (catalase, oxidase, and hippurate
hydrolysis), were chosen from a larger collection of strains
in order to achieve representatives from three different groups
of wild birds: thrushes (family
Muscicapidae, genus
Turdus),
raptors (families
Strigidae and
Accipitridae, genera
Asio and
Accipiter), and shorebirds (family
Scolopacidae, genera
Calidris,
Limicola,
Tringa) (Table
1). The presumptive bacterial species
identity was later validated using molecular methods. All isolates
were first tested in a multiplex PCR method that gives separate
species-specific amplifications of
C. jejuni and
C. coli genes
(
25). PCR conditions and reactions were performed as described
in the original study (
25). Template DNA for the PCRs consisted
either of purified chromosomal DNA (92 isolates; Puregene DNA
Isolation Kit; Gentra Systems, Minneapolis) or extracted DNA
from 48-h-old subcultures grown on heart infusion (HI) agar
(Difco; product no. 244400), supplemented with 5% sheep blood,
using a 20% Chelex-100 slurry (Bio-Rad; product no. 142-2842),
as described previously (
9). Clear positive amplicons specific
for
C. jejuni were observed for all but four tested isolates.
The remaining isolates were subjected to a previously described
combined PCR and restriction fragment analysis method (
10),
where three isolates gave
C. jejuni-pecific restriction patterns
and the last
C. coli-specific pattern (this isolate was excluded
from the study).
Susceptibility tests.
Susceptibility was tested quantitatively with an adjusted broth
microdilution test according to NCCLS guideline M31-A2. For
broth microdilution, microtiter trays were used with dehydrated
dilution ranges of custom-made panels of antimicrobial agents
(Trek Diagnostic Systems, United Kingdom). The agents included
in the panels are presented in Table
2. After inoculation of
the microtiter trays with 50 µl of a 200-fold-diluted
0.5 McFarland suspension in Mueller Hinton-II broth (MH-II broth;
Lab M; product no. Lab 39, supplemented with 0.2 IU/ml thymidine
phosphorylase; Sigma; product no. T7006) of a 48-h-old pure
culture on blood agar, the trays were incubated microaerobically
in a shaking incubator at 37°C for 24 h (80 to 100 rpm).
C. jejuni ATCC 33560 was used as the control strain. All isolates
from thrushes and one from an owl failed to grow sufficiently
in MH-II broth, and for these strains heart infusion (HI) broth
(Difco; product no. 238400) was used instead. The MICs were
defined as the lowest concentrations in the wells where no visual
growth could be observed.
View this table:
[in this window]
[in a new window]
|
TABLE 2. MIC values to different antimicrobial compounds in 137 Campylobacter jejuni isolates from wild shorebirds (A), thrushes (B), and raptors (C)a
|

RESULTS
Of the 139 bird isolates, 94 failed to grow sufficiently in
MH-II broth. For these isolates HI broth was used in the microdilution
tests. One isolate failed to grow also in the HI broth and,
consequentially, its resistance profile could not be determined.
Another isolate was identified as
C. coli and was omitted from
further analyses. The MICs for the control strain
C. jejuni ATCC 33560 to ciprofloxacin, nalidixic acid, and erythromycin
were always within tentative quality control (QC) ranges for
the agar dilution method (NCCLS document M31-A2), irrespective
of the broth used. The MIC of the control strain to doxycycline
was only once one dilution step below the QC ranges, and the
MIC to gentamicin was four out of six times one dilution step
below the QC ranges. For the other antimicrobial agents, QC
ranges did not exist yet, so the results were interpreted with
more care. For
C. jejuni ATCC 33560 the MIC to amoxicillin varied
between 4 and 8 µg/ml, to chloramphenicol the MIC varied
between

2 and 8 µg/ml, to metronidazole the MIC varied
between

0,5 and 1 µg/ml, to neomycin the MIC varied between

0,5 and 2 µg/ml, and to streptomycin the MIC varied between

1 and 2 µg/ml, irrespective of the broth used.
All isolates were found to be susceptible to chloramphenicol, erythromycin, gentamicin, neomycin, and streptomycin (Table 2). Low resistance prevalences (0.7 to 3.6%) were observed for four compounds: amoxicillin, ciprofloxacin, doxycycline, and nalidixic acid, whereas a moderate resistance prevalence (14.6%) was found to metronidazole (Table 2).
When all substances were considered, two of the bird species, long-eared owl and blackbird, more often carried resistant C. jejuni isolates than other species (Table 3). This was particularly evident for metronidazole. Notably, the eight isolates from long-eared owls showed resistance to four of the tested compounds, and one of these was simultaneously resistant to nalidixic acid and ciprofloxacin.
View this table:
[in this window]
[in a new window]
|
TABLE 3. Seasonal distribution of isolates resistant to tested antimicrobial agents (numbers of the isolates are placed in brackets)
|

DISCUSSION
The use of antimicrobial agents in the rearing of poultry and
other food-producing animals is perceived by many as a strong
threat to public health, as bacteria in these systems, including
pathogenic ones, are under strong selection for acquiring resistance
to antimicrobial compounds. The threat can be divided into two
parts: first, resistant zoonotic bacteria that survive all production
steps could end up in the food consumed by humans; second, selection
for anti-antimicrobial genes could spread these alleles within
clonal complexes of bacteria or be transferred horizontally
to other bacterial species. In the latter case, resistance genes
selected for in a harmless commensal bacterium could jump to
a pathogenic species, where human or animal health considerations
are much greater. Resistant genotypes could spread from farms
into the environment by a number of ways, but the important
question to ask is whether these genotypes can persist in, and
further spread to, any environmental reservoirs such as wild
birds. If so, a feed-back loop from one farm through the environmental
reservoir to the next could be possible.
Overall, the incidence of resistance to antimicrobial agents was low for the investigated wild bird isolates. There are a number of published studies in the human and veterinary literature on the degree of acquired resistance to antimicrobial compounds; many that report considerably higher incidences of resistance than those seen in this study (1). For instance, data obtained in the same lab as in this study on the occurrence of resistant isolates of C. jejuni in Dutch humans (1998 to 1999) and Dutch poultry (2000 to 2003) reported that 7.8% and 24.3% of investigated strains were resistant to amoxicillin, 23.4% and 36.3% to ciprofloxacin, and 16.9% and 27.1% to doxycycline, respectively (15). The wild birds in this study were sampled during their annual migrations between breeding and wintering areas and vice versa. Thus, the C. jejuni strains may have colonized the birds in areas far from the sampling site. However, values from Swedish broiler chickens (4) were rather similar to those observed in the wild bird isolates, with 7.1% of isolates resistant to ampicillin, 0.8% to enrofloxacine, and 0.8% to tetracycline (2001 to 2002; n = 127).
The highest resistance prevalences were seen in isolates from the raptor group, which consisted mainly of long-eared owls. From one of these owls, an isolate with resistance to both nalidixic acid and ciprofloxacin was retrieved. The resistance to fluoroquinolones is caused by a point mutation in the gyrA gene (18) and has been shown to occur rapidly both in vitro and in vivo in the presence of this class of antimicrobial compounds (13, 18, 24). The few studies that have examined genetic similarities of C. jejuni strains isolated from wild birds to those of chickens and humans have shown that wild bird strains generally are different from isolates from other sources, but that similar genetic fingerprints sometimes occur (5, 6). The finding of a quinolone-resistant C. jejuni isolate could thus represent a resistant phenotype that has originated within another reservoir. Long-eared owls are essentially nocturnal and feed mainly on small rodents (especially voles Microtinae, and mice Murinae), but they also include passerine birds in their diet (ca. 2 to 17% of identified remains from pellets [8]).
Elevated MIC values were also observed among wild bird isolates for amoxicillin, doxycycline, and metronidazole. For amoxicillin, however, all the five isolates in question produced MIC values that were only one dilution step above the breakpoint of 16 µg/ml (Table 2). The varying MICs of 4 to 8 µg/ml for the internal standard, C. jejuni ATCC 33560, to this compound indicate that the methodology may have been suboptimal. An allowance for a methodology error of one dilution step would place all isolates scored here as resistant below the breakpoint. The single isolate that showed resistance to doxycycline (Table 2), obtained from a Dunlin (Calidris alpina), grew in 4-dilution-steps higher concentration than did the isolates with the second highest MIC. Therefore, the elevated MIC in this isolate is more likely to reflect a true resistance. A total of 14.5% of all isolates had MIC values for metronidazole that exceeded the breakpoint. There was also a tendency to a bimodal MIC value distribution for this substance. Metronidazole-resistant isolates were found in all three bird groups but were more frequent among raptors and thrushes (Table 2). The mechanisms behind the resistance to metronidazole in Campylobacter spp. are not yet fully understood. Reduction of the 5-nitro group of the imidazole ring to nitro-radical anions responsible for the species-specific effects on DNA have been described in anaerobes and is probably also responsible for the activity in Campylobacter species. In the related bacterium Helicobacter pylori, resistance to metronidazole can result from the loss of activity of an oxygen-independent NADPH nitroreductase due to mutations in the rdxA gene. However, the existence of this pathway in Campylobacter spp. has not been validated (14). The observation that metronidazole resistance in C. jejuni is associated with strains isolated from birds was described previously by Stanley and Jones (22) and is confirmed by the results of the present study. Selection for metronidazole resistance by the use of dimetridazole derivatives in birds was considered highly unlikely, and a host phenotype relationship was suggested (22).
The present study provides valuable baseline data on MIC values in C. jejuni isolates from three groups of wild birds sampled in Sweden. Most of the host species studied here are not normally found close to human settlements, and the results could have been different if we had studied bird species that were more associated with human activities. Nevertheless, we found one bacterial isolate with resistance to quinolones, indicating that resistant genotypes can leak out into the wild bird reservoir.

ACKNOWLEDGMENTS
This work was supported financially by the Health Research Council
of Southeast Sweden (2001-02), the Uddenberg-Nordingska Foundation,
the Medical Faculty of Umeå University, and the Swedish
Research Council for Environment, Agricultural Sciences and
Spatial Planning (FORMAS) (2003-0795 and 2003-1146).
We thank Jelle-Jan van der Zwaag from CIDC-Lelystad for technical assistance and Christina Greko, Sweden, for valuable comments.

FOOTNOTES
* Corresponding author. Mailing address: Central Institute for Animal Disease Control (CIDC-Lelystad), 8219PH Lelystad, The Netherlands. Phone: 31-3202-38413. Fax: 31-3202-38153. E-mail:
dik.mevius{at}wur.nl.

Contribution no. 199 from Ottenby Bird Observatory. 

REFERENCES
1 - Aarestrup, F. M., and J. Engberg. 2001. Antimicrobial resistance of thermophilic Campylobacter. Vet. Res. 32:311-321.[CrossRef][Medline]
2 - Aarestrup, F. M., and H. C. Wegener. 1999. The effects of antibiotic usage in food animals on the development of antimicrobial resistance of importance for humans in Campylobacter and Escherichia coli. Microbes Infect. 1:639-644.[CrossRef][Medline]
3 - Allerberger, F., N. Al Jazrawi, P. Kreidl, M. P. Dierich, G. Feierl, I. Hein, and M. Wagner. 2003. Barbecued chicken causing a multi-state outbreak of Campylobacter jejuni enteritis. Infection 31:19-23.[CrossRef][Medline]
4 - Bengtsson, B., C. Greko, and C. Wallén. 2003. SVARM 2002 - Swedish veterinary antmicrobial resistance monitoring. National Veterinary Institute (SVA), Uppsala, Sweden.
5 - Broman, T., H. Palmgren, S. Bergstrom, M. Sellin, J. Waldenström, M. L. Danielsson-Tham, and B. Olsen. 2002. Campylobacter jejuni in black-headed gulls (Larus ridibundus): prevalence, genotypes, and influence on C. jejuni epidemiology. J. Clin. Microbiol. 40:4594-4602.[Abstract/Free Full Text]
6 - Broman, T., J. Waldenström, D. Dahlgren, I. Carlsson, I. Eliasson, and B. Olsen. 2004. Diversities and similarities in PFGE profiles of Campylobacter jejuni isolated from migrating birds and humans. J. Appl. Microbiol. 96:834-843.[CrossRef][Medline]
7 - Casewell, M., C. Friis, E. Marco, P. McMullin, and I. Phillips. 2003. The European ban on growth-promoting antibiotics and emerging consequences for human and animal health. J. Antimicrob. Chemother. 52:159-161.[Abstract/Free Full Text]
8 - Cramp, S. 1989. Handbook of the birds of Europe, the Middle East and North Africa. Oxford University Press, New York, N.Y.
9 - Engberg, J., S. L. On, C. S. Harrington, and P. Gerner-Smidt. 2000. Prevalence of Campylobacter, Arcobacter, Helicobacter, and Sutterella spp. in human fecal samples as estimated by a reevaluation of isolation methods for campylobacters. J. Clin. Microbiol. 38:286-291.[Abstract/Free Full Text]
10 - Férmer, C., and E. O. Engvall. 1999. Specific PCR identification and differentiation of the thermophilic campylobacters Campylobacter jejuni, C. coli, C. lari, and C. upsaliensis. J. Clin. Microbiol. 37:3370-3373.[Abstract/Free Full Text]
11 - Friedman, C. R., H. Neimann, H. C. Wegener, and R. V. Tauxe. 2000. Epidemiology of Campylobacter jejuni in the United States and other industrialized nations, p. 121-138. In I. Nachamkin and M. J. Blaser (ed.), Campylobacter. ASM Press, Washington, D.C.
12 - Hecker, M. T., D. C. Aron, N. P. Patel, M. K. Lehmann, and C. J. Donskey. 2003. Unnecessary use of antimicrobials in hospitalized patients: current patterns of misuse with an emphasis on the antianaerobic spectrum of activity. Arch. Intern. Med. 163:972-978.[Abstract/Free Full Text]
13 - Luo, N., O. Sahin, J. Lin, L. O. Michel, and Q. Zhang. 2003. In vivo selection of Campylobacter isolates with high levels of fluoroquinolone resistance associated with gyrA mutations and the function of the CmeABC efflux pump. Antimicrob. Agents Chemother. 47:390-394.[Abstract/Free Full Text]
14 - Mendz, G. L., and F. Megraud. 2002. Is the molecular basis of metronidazole resistance in microaerophilic organisms understood? Trends Microbiol. 10:370-375.[CrossRef][Medline]
15 - Mevius, D. J., and W. v. Pelt. 2003. Monitoring of antimicrobial resistance and antibiotic usage in animals in The Netherlands in 2002 (MARAN-2002). Central Institute for Disease Control (CIDC), Lelystadt, The Netherlands.
16 - Nygard, K., B. Gondrosen, and V. Lund. 2003. Water-borne disease outbreaks in Norway. Tidsskr. Nor Laegeforen. 123:3410-3413.[Medline]
17 - Oosterom, J. 1991. Epidemiological studies and proposed preventive measures in the fight against human salmonellosis. Int. J. Food Microbiol. 12:41-51.[CrossRef][Medline]
18 - Payot, S., A. Cloeckaert, and E. Chaslus-Dancla. 2002. Selection and characterization of fluoroquinolone-resistant mutants of Campylobacter jejuni using enrofloxacin. Microb. Drug Resist. 8:335-343.[CrossRef][Medline]
19 - Phillips, I., M. Casewell, T. Cox, B. De Groot, C. Friis, R. Jones, C. Nightingale, R. Preston, and J. Waddell. 2004. Does the use of antibiotics in food animals pose a risk to human health? A critical review of published data. J. Antimicrob. Chemother. 53:28-52.[Abstract/Free Full Text]
20 - Rodrigues, L. C., J. M. Cowden, J. G. Wheeler, D. Sethi, P. G. Wall, P. Cumberland, D. S. Tompkins, M. J. Hudson, J. A. Roberts, and P. J. Roderick. 2001. The study of infectious intestinal disease in England: risk factors for cases of infectious intestinal disease with Campylobacter jejuni infection. Epidemiol. Infect. 127:185-193.[Medline]
21 - Skirrow, M. B. 1994. Diseases due to Campylobacter, Helicobacter, and related bacteria. J. Comp. Pathol. 111:113-149.[CrossRef][Medline]
22 - Stanley, K. N., and K. Jones. 1998. High frequency of metronidazole resistance among strains of Campylobacter jejuni isolated from birds. Lett. Appl. Microbiol. 27:247-250.[CrossRef][Medline]
23 - Thorns, C. J. 2000. Bacterial food-borne zoonoses. Rev. Sci. Technol. 19:226-239.[Medline]
24 - van Boven, M., K. T. Veldman, M. C. de Jong, and D. J. Mevius. 2003. Rapid selection of quinolone resistance in Campylobacter jejuni but not in Escherichia coli in individually housed broilers. J. Antimicrob. Chemother. 52:719-723.[Abstract/Free Full Text]
25 - Vandamme, P., L. J. Van Doorn, S. T. al Rashid, W. G. Quint, van der Plas, J., V. L. Chan, and S. L. On. 1997. Campylobacter hyoilei Alderton et al. 1995 and Campylobacter coli Veron and Chatelain 1973 are subjective synonyms. Int. J. Syst. Bacteriol. 47:1055-1060.[Abstract/Free Full Text]
26 - van den Bogaard, A. E. 2001. Human health aspects of antibiotic use in food animals: a review. Tijdschr. Diergeneeskd. 126:590-595.[Medline]
27 - Waldenström, J., T. Broman, I. Carlsson, D. Hasselquist, R. P. Achterberg, J. A. Wagenaar, and B. Olsen. 2002. Prevalence of Campylobacter jejuni, Campylobacter lari, and Campylobacter coli in different ecological guilds and taxa of migrating birds. Appl. Environ. Microbiol. 68:5911-5917.[Abstract/Free Full Text]
Applied and Environmental Microbiology, May 2005, p. 2438-2441, Vol. 71, No. 5
0099-2240/05/$08.00+0 doi:10.1128/AEM.71.5.2438-2441.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Marrow, J., Whittington, J. K., Mitchell, M., Hoyer, L. L., Maddox, C.
(2009). PREVALENCE AND ANTIBIOTIC-RESISTANCE CHARACTERISTICS OF ENTEROCOCCUS SPP. ISOLATED FROM FREE-LIVING AND CAPTIVE RAPTORS IN CENTRAL ILLINOIS. J Wildl Dis
45: 302-313
[Abstract]
[Full Text]